NCT06829290 Influence of Sarcopenia on the Course of the Diseases
| NCT ID | NCT06829290 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitatsmedizin Mainz - 1. Medizinische Klinik |
| Condition | Liver Cirrhosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-10-01 |
| Primary Completion | 2026-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2024-10-01 with a primary completion date of 2026-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Frailty is a geriatric syndrome that primarily affects older patients, but also patients with severe illnesses. It is particularly common among oncology patients, but also among patients with gastrointestinal diseases such as liver cirrhosis or pancreatitis. Sarcopenia, a form of frailty, is defined as a loss of muscle quantity, quality and function. Currently, complex methods such as CT or bioimpedance measurement are available. However, simpler techniques such as ultrasound-based measurement could be alternatives, but still require further validation. In addition, serological muscle markers could support and simplify diagnostics. The aim of this project is to be able to estimate the prognosis of patients at an early stage by measuring sarcopenia using ultrasound and biomarkers.
Eligibility Criteria
Inclusion Criteria: * oncological patient in the field of gastrointestinal tumors * patients with liver cirrhosis * patients attending the intensive care unit Exclusion Criteria: * patients incapable of consenting * patients with congenital muscle diseases
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06829290 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Liver Cirrhosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06829290 currently recruiting?
Yes, NCT06829290 is actively recruiting participants. Contact the research team at maximilian.kremer@unimedizin-mainz.de for enrollment information.
Where is the NCT06829290 trial being conducted?
This trial is being conducted at Mainz, Germany.
Who is sponsoring the NCT06829290 clinical trial?
NCT06829290 is sponsored by Universitatsmedizin Mainz - 1. Medizinische Klinik. The trial plans to enroll 200 participants.